Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

24

Revenue 2017

Daiichi Sankyo

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Daiichi Sankyo's 2012 sales performance.

Daiichi Sankyo

Pfizer’s alliance with Sosei Heptares bears first fruit

Pfizer’s alliance with Sosei Heptares bears first fruit Pfizer is just one of Sosei Heptares’ big pharma partners, and the company has also attracted sizeable collaborations with AstraZeneca, Allergan, Novartis, and Daiichi-Sankyo.

AZ’s bet on Daiichi’s rival to Kadcyla pays off

AZ’s bet on Daiichi’s rival to Kadcyla pays off Pivotal phase 2 data backs investment. AstraZeneca has the positive pivotal trial it needed to justify its big investment in Daiichi’s HER2-targeting antibody-drug conjugate DS-8201, a rival ... There are no anti-HER2 therapies currently approved for

Oncology drives AstraZeneca, Genzyme boosts Sanofi

Oncology drives AstraZeneca, Genzyme boosts Sanofi AZ confirmed it will continue to drive oncology advancements, citing its recent partnership with Japan-based pharma group Daiichi Sankyo. ... Soriot adds: “The recently-announced collaboration with Daiichi Sankyo also broadened an exciting oncology

Second chance for AstraZeneca’s selumetinib with breakthrough designation

Second chance for AstraZeneca’s selumetinib with breakthrough designation AstraZeneca has also just paid out a hefty $1.35bn upfront payment to become partners with Daiichi Sankyo on its late-stage antibody drug conjugate for HER2+ breast cancer.

AZ makes $6.9bn play for Daiichi Sankyo HER2 drug

AZ makes $6.9bn play for Daiichi Sankyo HER2 drug Filing due later this year. AstraZeneca has made a big bet on a HER2-targeted antibody-drug conjugate developed by Daiichi Sankyo as it tries to add another pillar to its ... Daiichi Sankyo has said that means its drug can carry a greater cytotoxic

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OUTiCO

Providing an exceptional outsourcing service to the Pharma & Healthcare industries. We offer a sustainable approach and drive sales outcomes...

Latest intelligence

Behavioural Science in Healthcare
Personal health and wellbeing has never been more a part of the public conscious than it is now....
Why aren't doctors using digital therapeutics?
The digital therapeutics market is set to reach almost $1 billion by 2026 as wearables and apps continue to play an important role in enhancing healthcare. However, adoption of these...
Dec PME cover
Creativity in storytelling: why pharma must invest more in creativity
Chris Ross explores the value, the art and the much-rumoured death of creativity...

Infographics